Vanguard Group
BPTH

Vanguard Group’s Bio-Path Holdings Inc BPTH Stock Holding History

Vanguard Group’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,502
Closed -$15.7K – 4358
2024
Q4 		$15.7K Hold
13,502
– – ﹤0.01% 4270
2024
Q3 		$12.3K Hold
13,502
– – ﹤0.01% 4319
2024
Q2 		$27K Hold
13,502
– – ﹤0.01% 4340
2024
Q1 		$55.6K Buy
13,502
+1
+0% +$8 ﹤0.01% 4306
2023
Q4 		$125K Buy
13,501
+5,895
+78% +$62K ﹤0.01% 4276
2023
Q3 		$56.3K Sell
7,606
-4,348
-36% -$60.4K ﹤0.01% 4396
2023
Q2 		$426K Hold
11,954
– – ﹤0.01% 4163
2023
Q1 		$332K Buy
11,954
+871
+8% +$31.3K ﹤0.01% 4225
2022
Q4 		$335K Buy
11,083
+7
+0.1% +$307 ﹤0.01% 4200
2022
Q3 		$706K Hold
11,076
– – ﹤0.01% 4108
2022
Q2 		$857K Buy
11,076
+273
+3% +$18.4K ﹤0.01% 4138
2022
Q1 		$830K Hold
10,803
– – ﹤0.01% 4268
2021
Q4 		$815K Sell
10,803
-147
-1% -$13.6K ﹤0.01% 4318
2021
Q3 		$1.12M Hold
10,950
– – ﹤0.01% 4222
2021
Q2 		$1.46M Buy
10,950
+4,736
+76% +$584K ﹤0.01% 4060
2021
Q1 		$872K Buy
6,214
+1,376
+28% +$163K ﹤0.01% 4044
2020
Q4 		$339K Buy
4,838
+2,241
+86% +$168K ﹤0.01% 4020
2020
Q3 		$220K Buy
2,597
+771
+42% +$72.2K ﹤0.01% 3948
2020
Q2 		$184K Hold
1,826
– – ﹤0.01% 3932
2020
Q1 		$164K Hold
1,826
– – ﹤0.01% 3887
2019
Q4 		$292K Sell
1,826
-8
-0.4% -$1.5K ﹤0.01% 3884
2019
Q3 		$348K Buy
1,834
+438
+31% +$109K ﹤0.01% 3877
2019
Q2 		$374K Buy
1,396
+130
+10% +$41.2K ﹤0.01% 3876
2019
Q1 		$516K Buy
1,266
+980
+343% +$180K ﹤0.01% 3761
2018
Q4 		$20K Sell
286
-79
-22% -$13.6K ﹤0.01% 4118
2018
Q3 		$86K Hold
365
– – ﹤0.01% 4091
2018
Q2 		$218K Sell
365
-220
-38% -$153K ﹤0.01% 3965
2018
Q1 		$467K Buy
585
+108
+23% +$84.2K ﹤0.01% 3797
2017
Q4 		$386K Sell
477
-83
-15% -$107K ﹤0.01% 3805
2017
Q3 		$806K Sell
560
-51
-8% -$69.9K ﹤0.01% 3645
2017
Q2 		$948K Sell
611
-117
-16% -$245K ﹤0.01% 3579
2017
Q1 		$2.41M Buy
728
+4
+0.6% +$14.5K ﹤0.01% 3324
2016
Q4 		$3.91M Buy
724
+1
+0.1% +$4.84K ﹤0.01% 3144
2016
Q3 		$4.05M Buy
723
+152
+27% +$976K ﹤0.01% 3110
2016
Q2 		$4.55M Buy
571
+139
+32% +$1.41M ﹤0.01% 3035
2016
Q1 		$4.48M Buy
432
+4
+0.9% +$25.9K ﹤0.01% 3018
2015
Q4 		$2.14M Buy
428
+2
+0.5% +$11.7K ﹤0.01% 3366
2015
Q3 		$1.95M Buy
426
+11
+3% +$51.6K ﹤0.01% 3389
2015
Q2 		$1.91M Sell
415
-12
-3% -$65.6K ﹤0.01% 3442
2015
Q1 		$3.07M Buy
427
+6
+1% +$50.4K ﹤0.01% 3222
2014
Q4 		$4.49M Buy
421
+27
+7% +$279K ﹤0.01% 2958
2014
Q3 		$3.17M Buy
394
+25
+7% +$241K ﹤0.01% 3074
2014
Q2 		$4.5M Buy
+369
New +$4.04M ﹤0.01% 2889

Other funds holding BPTH

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group's BPTH Position: Q1 2025 in Review

Vanguard Group sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 13,502 shares — an estimated $15.7K sold.

Vanguard Group first reported a position in BPTH in Q2 2014 and held it in 43 quarters. The position peaked at $4.55M in Q2 2016. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.

  • Vanguard Group reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
  • Vanguard Group sold 13,502 Bio-Path Holdings Inc shares in Q1 2025, an estimated $15.7K.
  • Vanguard Group first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 43 quarters.
  • Vanguard Group's Bio-Path Holdings Inc position peaked at $4.55M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.

Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.